Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

💊 Pharmaceuticals

💻 Telehealth

Location

Hong Kong

Market Cap

USD 10.75 B

Share Price

USD 20.19

Avg Daily Volume

700,338

Change (1 day)

-7.09%

Change (1 year)

442.74%

Change (YTD)

308.70%

Regencell Bioscience Holdings Limited Current Ratio for the year ending June 30, 2024

Regencell Bioscience Holdings Limited Current Ratio is NA for the year ending June 30, 2024. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.

Regencell Bioscience Holdings Limited Current Ratio for the year ending June 30, 2023 was 19.15, a -32.72% change year over year.
Regencell Bioscience Holdings Limited Current Ratio for the year ending June 30, 2022 was 28.46.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Current Ratio	Interest Coverage Ratio	Return on Capital Employed (ROCE)	Return on Equity (ROE)

NasdaqCM: RGC

Regencell Bioscience Holdings Limited

CEO	Mr. Yat-Gai Au
IPO Date	July 16, 2021
Location	Hong Kong
Headquarters	First Commercial Building
Employees	12
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 💊 Pharmaceuticals 💻 Telehealth

Description

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Similar companies

AbbVie Inc.

USD 186.79

0.76%

Novo Nordisk A/S

USD 67.40

-0.61%

Roche Holding AG

USD 346.81

1.67%

Abbott Laboratories

USD 133.67

-2.71%

Novartis AG

USD 119.96

1.87%

AstraZeneca PLC

USD 139.42

-0.41%

Merck & Co., Inc.

USD 78.83

-1.05%

Amgen Inc.

USD 279.11

-0.44%

Pfizer Inc.

USD 24.24

-0.08%

Gilead Sciences, Inc.

USD 107.62

1.59%

Sanofi

USD 96.29

0.40%

Vertex Pharmaceuticals Incorporated

USD 443.40

-0.54%

Bristol-Myers Squibb Company

USD 46.65

-0.06%

Chugai Pharmaceutical Co., Ltd.

USD 52.04

-0.89%

GSK plc

USD 19.17

0.64%

CSL Limited

USD 154.14

-1.86%

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.14%

MERCK Kommanditgesellschaft auf Aktien

USD 130.63

1.54%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.21

-0.69%

Takeda Pharmaceutical Company Limited

USD 30.27

0.35%

Alnylam Pharmaceuticals, Inc.

USD 318.25

-1.15%

UCB SA

USD 197.49

0.30%

GE HealthCare Technologies Inc.

USD 74.86

2.90%

Bayer AG

USD 30.75

-0.14%

WuXi AppTec Co., Ltd.

USD 9.61

-2.55%

Celltrion, Inc.

USD 117.59

0.22%

Laboratory Corporation of America Holdings

USD 256.98

-0.66%

Hansoh Pharmaceutical Group Company Limited

USD 3.70

-0.14%

Royalty Pharma plc

USD 35.27

-1.78%

Insmed Incorporated

USD 101.74

-2.97%

Biogen Inc.

USD 126.92

-0.31%

Astellas Pharma Inc.

USD 9.70

1.17%

Innovent Biologics, Inc.

USD 9.80

-2.13%

Summit Therapeutics Inc.

USD 21.32

0.24%

Shionogi & Co., Ltd.

USD 17.52

-0.59%

Genmab A/S

USD 206.84

0.92%

Neurocrine Biosciences, Inc.

USD 126.71

-0.84%

Torrent Pharmaceuticals Limited

USD 37.60

0.25%

Exelixis, Inc.

USD 43.09

-1.01%

Mankind Pharma Limited

USD 26.88

0.15%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.53

0.36%

Akeso, Inc.

USD 11.66

-3.50%

BioMarin Pharmaceutical Inc.

USD 54.10

-0.07%

Ascendis Pharma A/S

USD 172.95

-0.03%

Lupin Limited

USD 22.50

0.04%

Swedish Orphan Biovitrum AB (publ)

USD 29.13

0.10%

Ipsen S.A.

USD 120.27

0.45%

Huadong Medicine Co., Ltd

USD 5.62

0.38%

Kyowa Kirin Co., Ltd.

USD 16.92

-1.27%

StockViz Staff

June 28, 2025

Any question? Send us an email